Overview

Corporate ProfileNantHealth is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth‘s unique systems-based approach to personalized healthcare integrates novel diagnostics with large-scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. In addition, NantHealth’s adaptive learning system, CLINICS, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time.
Stock Quote NH (Common Stock) $9.82 - 0.18 (1.80%)
ExchangeNASDAQ GS
Volume49,156
Today's Open$9.97
Previous Close$10.00
Data as of 01/17/17 1:49 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: NH.O.  Currently trading at $9.82 with a 52 week high of $21.00 and a 52 week low of $9.51.
Recent News

December 19, 2016

NantHealth to Present at the 35th Annual J.P. Morgan Healthcare Conference on January 9

CULVER CITY, Calif.--(BUSINESS WIRE)--Dec. 19, 2016-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that the company will present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017, at 5 p.m. Pacific Standard Time at the Westin St. Francis Hotel in San Francisco. An audio-only webcast of the presentation will be available at www.NantHealth.com. ...

Read More >

December 16, 2016

NantHealth, Inc. Announces Pricing of $100 Million of 5.50% Convertible Notes

CULVER CITY, Calif.--(BUSINESS WIRE)--Dec. 16, 2016-- NantHealth, Inc. (Nasdaq: NH) today announced the pricing of an aggregate of $100 million principal amount of 5.50% Convertible Senior Notes due 2021 (the "Notes"), in a private offering to qualified institutional buyers pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended (the "Act"), and a separate concurrent private placement under Section 4(a)(2) of the Act to...

Read More >

December 15, 2016

NantHealth, Inc. Announces Proposed $100 Million Convertible Notes Offering

CULVER CITY, Calif.--(BUSINESS WIRE)--Dec. 15, 2016-- NantHealth, Inc. (Nasdaq: NH) today announced its intention to offer, subject to market conditions and other factors, $100 million aggregate principal amount of convertible senior notes due 2021 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended (the “Act”). NantHealth also intends to grant t...

Read More >

Upcoming Events
There are currently no events scheduled.